These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

603 related articles for article (PubMed ID: 6459385)

  • 41. Non-T-cell-mediated cytotoxicity in mice with tumors induced by Moloney murine sarcoma virus (M-MuSV). II. Granulocyte-mediatd cytotoxicity against autochthonous target cells isolated from M-MuSV-induced tumors.
    Becker S; Haskill S
    J Natl Cancer Inst; 1980 Aug; 65(2):469-75. PubMed ID: 6249952
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of cytolytic T lymphocyte clones reactive with Moloney leukemia virus-associated antigens by monoclonal antibodies: a direct approach to the study of H-2 restriction.
    Weiss A; MacDonald HR; Cerottini JC; Brunner KT
    J Immunol; 1981 Feb; 126(2):482-5. PubMed ID: 6450244
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A crucial role of the H-2 D locus in the regulation of both the D- and the K-associated cytotoxic T lymphocyte response against Moloney leukemia virus, demonstrated with two Db mutants.
    Stukart MJ; Vos A; Boes J; Melvold RW; Bailey DW; Melief CJ
    J Immunol; 1982 Mar; 128(3):1360-4. PubMed ID: 6799575
    [No Abstract]   [Full Text] [Related]  

  • 44. Variants from a MLV-induced lymphoma selected for decreased sensitivity to NK lysis.
    Grönberg A; Kiessling R; Eriksson E; Hansson M
    J Immunol; 1981 Nov; 127(5):1734-9. PubMed ID: 6975295
    [No Abstract]   [Full Text] [Related]  

  • 45. T cell recognition of Moloney leukemia virus proteins. III. T cell proliferative responses against gp70 are associated with the production of a lymphokine inducing 20 alpha-hydroxysteroid dehydrogenase in splenic lymphocytes.
    Ihle JN; Lee JC; Rebar L
    J Immunol; 1981 Dec; 127(6):2565-70. PubMed ID: 6795277
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunoregulatory circuit among macrophage subsets for T cell-mediated cytotoxic response to tumor cells.
    Ting CC; Rodrigues D
    J Immunol; 1980 Mar; 124(3):1039-44. PubMed ID: 6444645
    [No Abstract]   [Full Text] [Related]  

  • 47. Vaccination of adult and newborn mice of a resistant strain (C57BL/6J) against challenge with leukemias induced by Moloney murine leukemia virus.
    Reif AE
    Cancer Res; 1985 Jan; 45(1):25-31. PubMed ID: 3965136
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Accessory cells in the in vitro generation of type C virus-specific T killer lymphocytes. II. Demonstration of a T helper cell in the spleen of in vivo primed mice.
    Gomard E; Wybier-Franqui J; Simmler MC; McKenzie IF; Levy JP
    J Immunol; 1981 Dec; 127(6):2291-5. PubMed ID: 6170695
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibody production and interaction with lymphoid cells in relation to tumor immunity in the Moloney sarcoma virus system.
    Harada M; Pearson G; Redmon L; Winters E; Kasuga S
    J Immunol; 1975 Apr; 114(4):1318-22. PubMed ID: 1090675
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protective effect of immune sera against transplantable Moloney virus-induced sarcoma and lymphoma.
    Pearson GR; Redmon LW; Bass LR
    Cancer Res; 1973 Jan; 33(1):171-8. PubMed ID: 4734119
    [No Abstract]   [Full Text] [Related]  

  • 51. Dissecting the immune response to moloney murine sarcoma/leukemia virus-induced tumors by means of a DNA vaccination approach.
    Milan G; Zambon A; Cavinato M; Zanovello P; Rosato A; Collavo D
    J Virol; 1999 Mar; 73(3):2280-7. PubMed ID: 9971811
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization to effector lymphocytes associated with immunity to murine sarcoma virus (MSV)-induced tumors. II. Repeated stimulation and proliferation in vitro of specific cytolytic T lymphocytes.
    Plata F; Jongeneel CV
    J Immunol; 1977 Aug; 119(2):623-9. PubMed ID: 196025
    [No Abstract]   [Full Text] [Related]  

  • 53. Moloney murine sarcoma virus oncogenesis in T-lymphocyte-deprived mice: biologic and immunologic studies.
    Collavo D; Zanovello P; Leuchars E; Davies AJ; Chieco-Bianchi L; Biasi G
    J Natl Cancer Inst; 1980 Jan; 64(1):97-104. PubMed ID: 6243378
    [No Abstract]   [Full Text] [Related]  

  • 54. Tumor inhibiting capacity of spleen and lymph node cells from mice with murine sarcoma virus (MSV-M)-induced tumors.
    Weiland E; Mussgay M
    Z Immunitatsforsch Exp Klin Immunol; 1975 Nov; 150(5):414-23. PubMed ID: 181922
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cell interactions in leukemia-associated immunosuppression: suppression of thymus-independent antibody responses by leukemia spleen cells (Moloney) in vitro is mediated by normal T cells.
    Caulfield MJ; Cerny J
    J Immunol; 1980 Jan; 124(1):255-60. PubMed ID: 6965291
    [No Abstract]   [Full Text] [Related]  

  • 56. Immune responses to weakly immunogenic virally induced tumors. VI. Comparison of the immune response of the hybrid to the immune responses of the parents reveals "hybrid responsiveness" effect.
    Devens B; Naor D
    J Immunol; 1980 Sep; 125(3):988-94. PubMed ID: 6447725
    [No Abstract]   [Full Text] [Related]  

  • 57. [Effect of the Friend leukemia virus on lymphocyte subpopulations in the mouse].
    Jezzi T; Premrov MG; Del Gobbo V; Garaci E
    Ann Ist Super Sanita; 1982; 18(3):513-5. PubMed ID: 6230037
    [No Abstract]   [Full Text] [Related]  

  • 58. Studies of the mechanisms for the induction of in vivo tumor immunity. III. Recruitment of host helper cells by donor T cells in adoptive transfer of cell-mediated immunity.
    Ting CC; Rodrigues D; Igarashi T
    J Immunol; 1979 Apr; 122(4):1510-8. PubMed ID: 221575
    [No Abstract]   [Full Text] [Related]  

  • 59. Requirement of histocompatible macrophages for the induction of a secondary cytotoxic response to syngeneic tumor cells in vitro.
    Taniyama T; Holden HT
    J Immunol; 1979 Jul; 123(1):43-9. PubMed ID: 312881
    [No Abstract]   [Full Text] [Related]  

  • 60. Stimulation of secondary anti-MSV cytolytic T lymphocytes with MBL-2 reconstituted membranes.
    Duprez V; Mescher MF; Burakoff SJ
    J Immunol; 1983 Jan; 130(1):493-5. PubMed ID: 6600194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.